Found: 6
Select item for more details and to access through your institution.
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36769-6
- By:
- Publication type:
- Article
CSF1R Protein Expression in Reactive Lymphoid Tissues and Lymphoma: Its Relevance in Classical Hodgkin Lymphoma.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0125203
- By:
- Publication type:
- Article
CD229 (Ly9) a Novel Biomarker for B-Cell Malignancies and Multiple Myeloma.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092154
- By:
- Publication type:
- Article
Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4758, doi. 10.3390/cancers13194758
- By:
- Publication type:
- Article
High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations.
- Published in:
- PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0229743
- By:
- Publication type:
- Article
DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling.
- Published in:
- Cancer Communications, 2023, v. 43, n. 7, p. 838, doi. 10.1002/cac2.12427
- By:
- Publication type:
- Article